Shandong Weigao boosts treasury holdings with latest H share repurchase

Shandong Weigao Group Medical Polymer Company Limited disclosed on December 19, 2025, that it repurchased 80,000 H shares on the Exchange. The shares were bought at prices ranging from HK$5.28 to HK$5.29, with an aggregate price paid of HK$422,600. This transaction resulted in a 0.0018% decrease in issued shares (excluding treasury shares) relative to the opening balance of 4,491,348,724 shares.

Following the repurchase, the number of issued shares (excluding treasury shares) stands at 4,491,268,724, while the number of treasury shares increased by 80,000 to a total of 31,063,600. The total issued shares remain at 4,522,332,324.

The company holds a repurchase mandate, authorized on May 27, 2025, for up to 451,560,392 shares. To date, 24,415,200 shares, representing 5.4069% of the issued shares (excluding treasury shares) as of the mandate date, have been repurchased on the Exchange. A moratorium period for new share issues or treasury share sales after this repurchase extends until January 18, 2026.